Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats

Burns

Volumn 35, Issue 2, 2009, Pages 270-273

  Uygur, Fatih ^a   Öncül, Oral ^a   Evinç, Rahmi ^a   Diktas, Hüsrev ^a   Acar, Ali ^a   Ülkür, Ersin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acinetobacter baumannii; Burn infection; Wound dressing

Indexed keywords

CHLORHEXIDINE ACETATE; SULFADIAZINE SILVER;

ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BURN; BURN DRESSING; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BANDAGES; BURNS; CHLORHEXIDINE; DRUG DELIVERY SYSTEMS; MALE; POLYESTERS; POLYETHYLENES; RATS; RATS, INBRED BB; RATS, WISTAR; SILVER SULFADIAZINE;

EID: 59149093343     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.05.020     Document Type: Article

References (29)

1. Church D., Elsayed S., Reid O., Winston B., and Lindsay R. Burn wound infections. Clin Microbiol Rev 19 (2006) 403-434
2. Sharma B.R. Infection in patients with severe burns: causes and prevention thereof. Infect Dis Clin North Am 21 (2007) 745-759
3. Santucci S.G., Gobara S., Santos C.R., Fontana C., and Levin A.S. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 53 (2003) 6-13
4. Bergogne-Berezin E. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J Hosp Infect 30 (1995) 441-452
5. Sengupta S., Kumar P., Ciraj A.M., and Shivananda P.G. Acinetobacter baumannii, an emerging nosocomial pathogen in the burns unit Manipal, India. Burns 27 (2001) 140-144
6. Chim H., Tan B.H., and Song C. Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate. Burns 33 (2007) 1008-1014
7. Roberts S.A., Findlay R., and Lang S.D.R. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 48 (2001) 228-232
8. Trottier V., Segura P.G., Namias N., King D., Pizano L.R., and Schulman C.I. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res 28 (2007) 248-254
9. Lyytikäinen O., Köljalg S., Härmä M., and Vuopio-Varkila J. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burn unit: emergence of resistance to imipenem. J Hosp Infect 31 (1995) 41-54
10. Minnangati V.R., and Cunha B.A. Acinetobacter baumannii-associated arterial line infection. Am J Infect Control 28 (2006) 376-377
11. Manafi A., Hashemlou A., Momeni P., and Moghimi H.R. Enhancing drugs absorption through third-degree burn wound eschar. Burns 34 (2008) 698-702
12. Kucan J.D., and Heggers J.P. The potential benefit of 5% sulfamylon solution in the treatment of Acinetobacter baumannii-contaminated traumatic war wound. J Burns Wounds 23 (2005) 4e, 3
13. Bridges K., and Lowbury E.J. Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. J Clin Pathol 30 (1977) 160-164
14. Ip M., Lui S.L., Poon V.K., Lung I., and Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55 (2006) 59-63
15. ®) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. J Burn Care Rehabil 26 (2005) 430-433
16. Ülkür E., Öncül O., Karagöz H., Yeriz E., and Celiköz B. Comparison of silver-coated dressing (Acticoat™), chlorhexidine acetate 0.5% (Bactigrass™), and fusidic acid 2% (Fucidin™) for topical antibacterial effect in methicillin-resistant staphylococci contaminated, full-skin thickness rat burn wounds. Burns 31 (2005) 874-877
17. Walker H.L., and Mason A.D. A standard animal burn. J Trauma 8 (1968) 1049-1051
18. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., and Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 43 (2005) 1632-1639
19. Dunn K., and Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 30 (2004) S1-S9
20. Fong J., and Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomed 1 (2006) 441-449
21. Dowsett C. An overview of Acticoat dressing in wound management. Br J Nurs 12 (2003) S44-S49
22. Wright J.B., Lam K., Hanson D., and Burrel R.E. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 27 (1999) 344-350
23. Stephen-Haynes J., and Toner L. Assessment and management of wound infection: the role of silver. Br J Commun Nurs 12 (2007) S6 8,10-2
24. Percival S.L., Bowler P.G., and Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 60 (2005) 1-7
25. Lansdown A.B., and Silver I. Its antibacterial properties and mechanism of action. J Wound Care 4 (2002) 125-130
26. Atiyeh B.S., Costagliola M., Hayek S.N., and Dibo S.A. Effect of silver on burn wound infection control and healing: review of the literature. Burns 33 (2007) 139-148 [Epub 29 Nov 2006]
27. Fraser J.F., Bodman J., Sturgess R., Faoagali J., and Kimble R.M. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 30 (2004) 35-41
28. Rosenberg A., Alatary S.D., and Peterson A.F. Safety and efficacy of the antiseptic chlorhexidine gluconate. Surg Gynaecol Obstet 143 (1976) 789-792
29. Hidalgo E., and Dominguez C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro 15 (2001) 271